Genetically Targeted Clinical Trials in Parkinson's Disease: Learning from the Successes Made in Oncology.

Sjögren, Magnus; Huttunen, Henri J; Svenningsson, Per; Widner, Håkan

Sjögren, Magnus; Huttunen, Henri J; Svenningsson, Per; Widner, Håkan.

Affiliation

Sjögren M; Herantis Pharma Plc, Bertel Jungin Aukio 1, 02600 Espoo, Finland.
Huttunen HJ; Department Health Sciences, Umeå University, 907 36 Umeå, Sweden.
Svenningsson P; Herantis Pharma Plc, Bertel Jungin Aukio 1, 02600 Espoo, Finland.
Widner H; Department of Neurology, Karolinska University Hospital, 171 77 Stockholm, Sweden.

Genes (Basel) ; 12(10)2021 09 28.

Article in En | MEDLINE | ID: mdl-34680924

Subject(s)

Clinical Trials as Topic; Parkinson Disease/genetics; Antiparkinson Agents/therapeutic use; Humans; Molecular Targeted Therapy/methods; Parkinson Disease/drug therapy; Precision Medicine/methods

Key words

Parkinson's disease; clinical trials; genetic targets; neurodegenerative disorders; oncology; precision medicine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Clinical Trials as Topic Limits: Humans Language: En Journal: Genes (Basel) Year: 2021 Type: Article Affiliation country: Finland

Fulltext

XML

PubMed Links

Search on Google